Prescriva Review: Four-Week Prices and Refund Questions

We would compare Prescriva's shorter plan first if you want a cash-pay compounded injection package with consultation and shipping included. The lower long-plan headline deserves consideration after the payment timetable is clear. A shorter commitment is easier to budget while you learn whether the service suits you.

Start with the plan you are actually buying

The semaglutide product page advertises $209 on its month-to-month plan, or a $139 monthly equivalent on the 52-week plan. It describes a compounded injection with clinician consultation, medication, shipping and ongoing support included. That is a useful package to price, but the lower figure is tied to a different treatment term.

Tirzepatide is advertised at $249 month-to-month or $209 on the 52-week plan, also with consultation, medication and shipping. Ask for the prescribed preparation, quantity and usable supply. The page does not turn that long-plan equivalent into a confirmed monthly card charge, nor does it establish that every patient receives the same prescription.

The four-week wording changes the budget question

Prescriva's pricing page says its injection prices are per four-week supply and that multi-month plans are charged once per plan period. Yet its annual-cost FAQ multiplies twelve monthly payments to estimate $2,508 for semaglutide and $2,988 for tirzepatide. The public wording does not reconcile those calculations with the four-week supply description.

Our four-week versus monthly cost guide explains why the distinction matters. Obtain the dates and amounts of the first and later charges, plus the supply each buys. The plan's quoted monthly equivalent is not enough to establish your upfront payment or renewal total.

Canceling the next term does not refund the current one

The refund policy places the first charge at completion of the intake assessment. It promises the most recent billing cycle back after medical disqualification, with earlier cycles excluded. It also provides refunds when medication is unavailable without a suitable alternative, or an assessment goes unreviewed beyond the stated timeframe. Those are specific conditions, not a general right to return unused treatment.

Cancellation requires no advance notice under that policy, is processed immediately and takes effect at the end of the paid cycle. Ordinary unused portions are not refunded. Completed consultations and compounded, shipped medicines also have refund restrictions. Use our cancellation guide before treating a prepaid term as a refundable trial.

Get the rejection refund amount in writing

The terms describe a full consultation-fee refund after medical ineligibility. Ask which agreement and refund amount apply to your order.

That is narrower wording than the policy's current-cycle promise. Obtain the refundable amount after review and ask how the completed-consultation exception applies.

The terms also identify RedRock Pharmacy, Health Warehouse and Precision Medicine as possible dispensers. The clinician selects a pharmacy according to clinical appropriateness, state licensing and availability, and the assignment can change between orders. Request the actual facility before using our pharmacy verification guide. A partner list is not an independent license check or a promise of your preferred dispenser.

Know who handles the medical decisions

Prescriva's consent identifies OpenLoop Health and affiliated professional corporations as the independent clinical network. It says an OpenLoop clinician consults after checkout to determine prescription eligibility. Prescriva is the management and technology organization, rather than your treating practice. Neither completing the preliminary assessment nor paying guarantees a prescription.

The same consent describes subscription programs as automatically renewing and requires an explicit cancellation request before the next payment is processed. Keep the renewal date and accepted cancellation instructions with your quote. Acting before processing is a more dependable way to stop another payment than assuming a request afterward will reverse it.

Coverage and support need prescription-specific answers

The FAQ describes service in most U.S. states, with availability confirmed during assessment. That is a reason to establish your location's eligibility before planning a refill or transferring care. It does not confirm every medication or pharmacy option for every address, and we have not independently checked each clinician's state authority.

Its advertised package includes care-team messaging, progress tracking and compounded medication. Those features may suit someone comfortable managing care online. They do not identify a guaranteed response time, your assigned clinician or a complete included lab panel. Ask who manages dose changes, when follow-up occurs and whether required testing adds to the bill.

The platform name does not identify the preparation

Prescriva's website identifies Prescriva LLC as the platform operator and distinguishes its administrative role from independent care. Its homepage names semaglutide and tirzepatide weight-loss treatments separately from lower-dose longevity options. We would keep those purchases separate; a microdose headline does not price the conventional injection plan.

The site states that compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness or quality. Published brand-name comparisons do not establish equivalent preparations or manufacturer affiliation. We have not enrolled, received medication or tested support, so this assessment concerns the disclosed purchase and care arrangements.

Our take

We would price the shorter plan first. Consultation, medication and shipping make the package worth comparing, but the longest term is a commitment to assess after you know how its online care suits you.